| Financial Year |
March 31 2023 |
| Monetary Funds |
80,289,852.99 |
| Held-for-trading Financial Assets |
53,000,000.00 |
| Notes Receivable |
3,556,936.17 |
| Accounts Receivable |
109,618,400.52 |
| Advances to Suppliers |
1,566,414.52 |
| Other Receivables |
2,199,664.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
93,737,419.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,674,366.48 |
| Total Current Assets |
377,207,768.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
709,165,284.52 |
| Under-construction Projects |
6,950,142.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,407,587.55 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
5,416,990.11 |
| Deferred Income Tax Assets |
6,732,540.94 |
| Other Non-Current Assets |
6,484,969.65 |
| Sub-Total of Non-Current Assets |
838,301,038.44 |
| Total Assets |
1,215,508,806.46 |
| Short-Term Loans |
136,400,242.52 |
| Trading Financial liabilities |
-- |
| Notes Payable |
52,490,082.49 |
| Accounts Payable |
146,155,454.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,290,411.86 |
| Taxes Payable |
1,267,781.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,487,133.82 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,096,439.56 |
| Other Current Liabilities |
907,326.53 |
| Sub-Total of Current Liabilities |
354,544,163.67 |
| Long-term Loans |
201,103,990.52 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
232,862,537.39 |
| Total Liabilities |
587,406,701.06 |
| Paid-In Capital(Or Share Stock) |
144,000,000.00 |
| Capital Surplus |
207,566,682.57 |
| Surplus Reserve |
34,684,055.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
243,254,969.77 |
| Minority Stockholder's Interest |
1,747,906.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
626,354,199.13 |
| Owner's Equity（Stockholder's Equity） |
628,102,105.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,215,508,806.46 |
